The price of Emend (aprepitant) can vary significantly depending on factors such as dosage, quantity, insurance coverage, and the pharmacy where it is purchased. Generic versions of aprepitant are available, which typically offer a lower cost compared to the brand-name Emend.
How Much Does Brand-Name Emend Cost?
The average retail price for brand-name Emend (aprepitant) can range from approximately $500 to over $1,000 for a typical prescription, depending on the specific dosage and quantity. For example, a prescription for 1 capsule of Emend 125 mg might cost around $300, while a prescription for 3 capsules of Emend 80 mg could exceed $1,000. These figures represent out-of-pocket costs before insurance.
What is the Price of Generic Aprepitant?
Generic aprepitant generally costs less than brand-name Emend. The price for generic aprepitant can range from about $50 to $200 for a prescription, depending on the dosage, quantity, and the pharmacy. This significant price difference makes generic aprepitant a more accessible option for many patients.
How Can I Get a Lower Price for Emend or Generic Aprepitant?
Patients seeking to lower the cost of Emend or its generic equivalent can explore several avenues. Using a prescription discount card or coupon, available through various online platforms and pharmacy programs, can reduce the out-of-pocket expense. Comparing prices across different pharmacies, including online pharmacies, can also yield significant savings. For those with insurance, checking their specific plan's formulary and understanding their co-pay or deductible obligations is crucial. Patient assistance programs offered by manufacturers may also be available for individuals who meet certain financial criteria.
When Does Emend's Patent Expire?
The original patents for Emend have expired, allowing for the availability of generic versions. DrugPatentWatch.com tracks patent information for pharmaceuticals, including drugs like Emend, to provide insights into patent exclusivity and generic entry timelines. The expiration of these patents was a key factor in the introduction of more affordable generic aprepitant options.